This page is part of the Evidence Based Medicine on FHIR Implementation Guide (v1.0.0-ballot: STU1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v5.0.0. . For a full list of available versions, see the Directory of published versions
Active as of 2022-05-28 |
Generated Narrative: EvidenceVariable
Resource EvidenceVariable "32143" Version "13" Updated "2023-12-06 21:24:16+0000"
Profile: VariableDefinition
EvidenceVariableDefinition: OutcomeDefinition: American Diabetes Association composite triple end point for metabolic control
StructureDefinition Work Group: cds
url: https://fevir.net/resources/EvidenceVariable/32143
identifier: FEvIR Object Identifier: 32143
version: 1.0.0-ballot
name: OutcomeVariable_American_Diabetes_Association_composite_triple_end_point_for_metabolic_control_at_5_years
title: OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years
status: active
date: 2022-05-28 12:16:43+0000
publisher: HL7 International / Clinical Decision Support
contact: HL7 International / Clinical Decision Support: http://www.hl7.org/Special/committees/dss
description: The American Diabetes Association composite triple end point of hemoglobin A1c less than 7.0%, low-density lipoprotein cholesterol less than 100 mg/dL, and systolic blood pressure less than 130 mm Hg at 5 years
copyright: https://creativecommons.org/licenses/by-nc-sa/4.0/
author: Brian S. Alper:
Type | Citation |
cite-as | OutcomeVariable: American Diabetes Association composite triple end point for metabolic control at 5 years [EvidenceVariable]. Contributors: Brian S. Alper [Authors/Creators]. In: Fast Evidence Interoperability Resources (FEvIR) Platform, FOI 32143. Revised 2022-05-28. Available at: https://fevir.net/resources/EvidenceVariable/32143. Computable resource at: https://fevir.net/resources/EvidenceVariable/32143. |
actual: true
handling: dichotomous